Vertex Pharmaceuticals Incorporated VRTX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.30B | 7.85B | 7.25B | 6.61B | 6.29B |
| Total Receivables | 2.31B | 2.13B | 2.00B | 2.05B | 1.95B |
| Inventory | 2.25B | 1.77B | 1.77B | 1.69B | 1.63B |
| Prepaid Expenses | 732.10M | 720.50M | 672.70M | 736.20M | 694.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 94.60M | 71.40M | 48.10M | 117.10M | 14.90M |
| Total Current Assets | 11.69B | 12.54B | 11.73B | 11.20B | 10.57B |
|
|
|||||
| Total Current Assets | 11.69B | 12.54B | 11.73B | 11.20B | 10.57B |
| Net Property, Plant & Equipment | 3.33B | 3.33B | 3.29B | 3.08B | 3.02B |
| Long-term Investments | 2.42B | 1.09B | 1.09B | 1.09B | 1.09B |
| Goodwill | 2.42B | 1.09B | 1.09B | 1.09B | 1.09B |
| Total Other Intangibles | 8.52B | 412.80M | 418.50M | 424.20M | 429.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.17B | 4.18B | 4.12B | 4.05B | 3.95B |
| Total Assets | 32.74B | 27.42B | 26.48B | 25.64B | 24.86B |
|
|
|||||
| Total Accounts Payable | 472.60M | 429.50M | 489.30M | 461.70M | 420.30M |
| Total Accrued Expenses | 3.24B | 3.18B | 2.98B | 2.78B | 3.61B |
| Short-term Debt | 999.60M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 82.80M | -- |
| Total Finance Division Other Current Liabilities | 293.00M | 329.40M | 407.10M | 534.60M | 441.50M |
| Total Other Current Liabilities | 293.00M | 329.40M | 407.10M | 534.60M | 441.50M |
| Total Current Liabilities | 5.00B | 3.94B | 3.88B | 3.86B | 4.48B |
|
|
|||||
| Total Current Liabilities | 5.00B | 3.94B | 3.88B | 3.86B | 4.48B |
| Long-Term Debt | 3.50B | -- | -- | -- | -- |
| Short-term Debt | 999.60M | -- | -- | -- | -- |
| Capital Leases | 1.98B | 1.98B | 1.99B | 1.95B | 1.83B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.35B | 1.26B | 1.26B | 1.16B | 1.23B |
| Total Liabilities | 11.83B | 7.18B | 7.12B | 6.98B | 7.54B |
|
|
|||||
| Common Stock & APIC | 4.51B | 4.51B | 4.75B | 5.12B | 5.01B |
| Retained Earnings | 16.34B | 15.69B | 14.59B | 13.56B | 12.37B |
| Treasury Stock & Other | 57.20M | 48.50M | 24.80M | -15.90M | -64.50M |
| Total Common Equity | 20.91B | 20.25B | 19.36B | 18.67B | 17.32B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.91B | 20.25B | 19.36B | 18.67B | 17.32B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.91B | 20.25B | 19.36B | 18.67B | 17.32B |
|
|
|||||